Thousands of people have died as a result of the ongoing SARS-CoV-2 (COVID-19) outbreak, and the number of illnesses is rising every day. It has grown to be the biggest risk to public health. Technologies for single-cell omics are useful for characterizing transcriptional alterations and variations in gene expression during SARS-CoV-2 infection. Creative Biolabs is a leading provider of single-cell omics services, offering customized single-cell sequencing and analysis tools to expedite the development of SARS-CoV-2 (COVID-19) therapies.

Significant progress has been made in the study of SARS-CoV-2 recently. According to research, SARS-CoV-2 primarily uses ACE2 as a receptor for cellular entry, and this process depends on the activity of the protease TMPRSS2 and the replacement cathepsin B/L. Here, we offer single-cell RNA sequencing (scRNA-seq) to thoroughly describe the alterations in gene expression in various organs and cells from COVID-19 patients. It allows us to make educated guesses about the potential genes implicated in the virus's entrance and determine which cell type is most susceptible to infection with SARS-CoV-2.

Check our single cell for COVID-19